RGP120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine (NIAID)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRGP120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine (NIAID)

Drug Alias NameSynVac

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Vaccine type > Univalent vaccineVaccines > Development/production technology > Synthetic peptide vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A